Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivo.
Advances in cancer therapy have increased the rate of survival of young cancer patients; however, female lymphoma patients frequently face a temporary or permanent loss of fertility when treated with traditional cytotoxic agents. The potential loss of fertility is an important concern that can influ...
Main Authors: | Richard W Ahn, Susan L Barrett, Meera R Raja, Jennifer K Jozefik, Lidia Spaho, Haimei Chen, Marcel B Bally, Andrew P Mazar, Michael J Avram, Jane N Winter, Leo I Gordon, Lonnie D Shea, Thomas V O'Halloran, Teresa K Woodruff |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3603968?pdf=render |
Similar Items
-
Arsenic Trioxide: Pharmacological Applications
by: German Madrigal Redondo, et al.
Published: (2023-04-01) -
Response to arsenic trioxide in dental treatment
by: Chen Gin
Published: (2013-06-01) -
Arsenic trioxide as an inducer of immunogenic cell death
by: Oliver Kepp, et al.
Published: (2023-12-01) -
In silico mechanisms of arsenic trioxide-induced cardiotoxicity
by: Yacong Li, et al.
Published: (2022-12-01) -
Factors determining sensitivity and resistance of tumor cells to arsenic trioxide.
by: Serkan Sertel, et al.
Published: (2012-01-01)